Page last updated: 2024-11-04

sulfasalazine and Cell Transformation, Neoplastic

sulfasalazine has been researched along with Cell Transformation, Neoplastic in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wada, T1
Ishimoto, T1
Seishima, R1
Tsuchihashi, K1
Yoshikawa, M1
Oshima, H1
Oshima, M1
Masuko, T1
Wright, NA1
Furuhashi, S1
Hirashima, K1
Baba, H1
Kitagawa, Y1
Saya, H1
Nagano, O1
Balza, E1
Castellani, P1
Delfino, L1
Truini, M1
Rubartelli, A1

Other Studies

2 other studies available for sulfasalazine and Cell Transformation, Neoplastic

ArticleYear
Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
    Cancer science, 2013, Volume: 104, Issue:10

    Topics: Adenocarcinoma; Amino Acid Transport System y+; Animals; Biomarkers, Tumor; Cell Transformation, Neo

2013
The pharmacologic inhibition of the xc- antioxidant system improves the antitumor efficacy of COX inhibitors in the in vivo model of 3-MCA tumorigenesis.
    Carcinogenesis, 2013, Volume: 34, Issue:3

    Topics: Adult; Aged; Amino Acid Transport System y+; Animals; Anticarcinogenic Agents; Antioxidants; Cell Tr

2013